Loading…
The prevalence of inflammatory bowel disease in an Israeli Arab population
To determine the prevalence of inflammatory bowel disease among the 1.5million Arab residents in Israel who represent 20% of the total population. Family physicians in all Arab towns and villages were contacted to obtain information on patients with inflammatory bowel disease. Relevant clinical data...
Saved in:
| Published in: | Journal of Crohn's and colitis 2013-06, Vol.7 (5), p.e159-e163 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c395t-9ae7964f22165e0818685d98e0ee92519f1c0847203384d95edfcd569c93e27e3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c395t-9ae7964f22165e0818685d98e0ee92519f1c0847203384d95edfcd569c93e27e3 |
| container_end_page | e163 |
| container_issue | 5 |
| container_start_page | e159 |
| container_title | Journal of Crohn's and colitis |
| container_volume | 7 |
| creator | Zvidi, Ibrahim Fraser, Gerald M. Niv, Yaron Birkenfeld, Shlomo |
| description | To determine the prevalence of inflammatory bowel disease among the 1.5million Arab residents in Israel who represent 20% of the total population.
Family physicians in all Arab towns and villages were contacted to obtain information on patients with inflammatory bowel disease. Relevant clinical data were retrieved and updated to December 31, 2009.
Information was obtained from 23/71 municipalities approached (representing 200,000 out of 1.5million Arabs). There were 64 confirmed cases of Crohn's disease indicating a prevalence rate of 32/100,000. The rate of smoking within this cohort was lower than in the general population (1.5% vs. 40%; P |
| doi_str_mv | 10.1016/j.crohns.2012.07.026 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1321334168</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1873994612003510</els_id><sourcerecordid>1321334168</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-9ae7964f22165e0818685d98e0ee92519f1c0847203384d95edfcd569c93e27e3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMorq7-A5EcvbTmq2lyEUT8RPCynkM2nbJZ2qYmreK_t2vVo6cZmOedYR6EzijJKaHycpu7GDZdyhmhLCdlTpjcQ0dUlTITotT73z3PtBZygY5T2hJS6KJUh2jBmGZUSHmEnlYbwH2Ed9tA5wCHGvuubmzb2iHET7wOH9DgyiewCaYRth1-TNFC4_F1tGvch35s7OBDd4IOatskOP2pS_R6d7u6ecieX-4fb66fM8d1MWTaQqmlqBmjsgCiqJKqqLQCAqBZQXVNHVGiZIRzJSpdQFW7qpDaaQ6sBL5EF_PePoa3EdJgWp8cNI3tIIzJUM4o54JKNaFiRidVKUWoTR99a-OnocTsLJqtmS2anUVDSjNZnGLnPxfGdQvVX-hX2wRczQBMf757iCY5v_NX-QhuMFXw_1_4AvmihFc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1321334168</pqid></control><display><type>article</type><title>The prevalence of inflammatory bowel disease in an Israeli Arab population</title><source>Oxford Journals Online</source><creator>Zvidi, Ibrahim ; Fraser, Gerald M. ; Niv, Yaron ; Birkenfeld, Shlomo</creator><creatorcontrib>Zvidi, Ibrahim ; Fraser, Gerald M. ; Niv, Yaron ; Birkenfeld, Shlomo</creatorcontrib><description>To determine the prevalence of inflammatory bowel disease among the 1.5million Arab residents in Israel who represent 20% of the total population.
Family physicians in all Arab towns and villages were contacted to obtain information on patients with inflammatory bowel disease. Relevant clinical data were retrieved and updated to December 31, 2009.
Information was obtained from 23/71 municipalities approached (representing 200,000 out of 1.5million Arabs). There were 64 confirmed cases of Crohn's disease indicating a prevalence rate of 32/100,000. The rate of smoking within this cohort was lower than in the general population (1.5% vs. 40%; P<0.001). There were 44 confirmed cases of ulcerative colitis with a prevalence rate of 22/100,000. The percentage of active smokers in this cohort was 18%. Clinical remission or mild activity was observed in 75% of patients in both cohorts at the time of the survey. Fourteen patients (21%) had undergone surgery for Crohn's disease, whereas none had undergone surgery for ulcerative colitis. Twenty-eight (42%) patients with Crohn's disease and 20 (45%) with ulcerative colitis were on maintenance therapy with 5-aminosalicylic acid. Only 18% with Crohn's disease and 6.8% with ulcerative colitis had received anti-tumor necrosis factor. The most prevalent extra-intestinal manifestations were perianal disease (18%) in Crohn's disease, and arthralgia or arthritis (6.8%) in ulcerative colitis.
We found a low prevalence rate of inflammatory bowel disease in the Israeli Arab population.</description><identifier>ISSN: 1873-9946</identifier><identifier>EISSN: 1876-4479</identifier><identifier>DOI: 10.1016/j.crohns.2012.07.026</identifier><identifier>PMID: 22921466</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Arabs ; Arthralgia - complications ; Arthritis - complications ; Child ; Colitis, Ulcerative - complications ; Colitis, Ulcerative - drug therapy ; Colitis, Ulcerative - ethnology ; Crohn Disease - drug therapy ; Crohn Disease - ethnology ; Crohn Disease - surgery ; Crohn's disease ; Epidemiology ; Family aggregation ; Female ; Humans ; Inflammatory bowel disease ; Israel - epidemiology ; Maintenance Chemotherapy ; Male ; Mesalamine - therapeutic use ; Middle Aged ; Prevalence ; Smoking - ethnology ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; Ulcerative colitis ; Young Adult</subject><ispartof>Journal of Crohn's and colitis, 2013-06, Vol.7 (5), p.e159-e163</ispartof><rights>2012 European Crohn's and Colitis Organisation</rights><rights>Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-9ae7964f22165e0818685d98e0ee92519f1c0847203384d95edfcd569c93e27e3</citedby><cites>FETCH-LOGICAL-c395t-9ae7964f22165e0818685d98e0ee92519f1c0847203384d95edfcd569c93e27e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22921466$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zvidi, Ibrahim</creatorcontrib><creatorcontrib>Fraser, Gerald M.</creatorcontrib><creatorcontrib>Niv, Yaron</creatorcontrib><creatorcontrib>Birkenfeld, Shlomo</creatorcontrib><title>The prevalence of inflammatory bowel disease in an Israeli Arab population</title><title>Journal of Crohn's and colitis</title><addtitle>J Crohns Colitis</addtitle><description>To determine the prevalence of inflammatory bowel disease among the 1.5million Arab residents in Israel who represent 20% of the total population.
Family physicians in all Arab towns and villages were contacted to obtain information on patients with inflammatory bowel disease. Relevant clinical data were retrieved and updated to December 31, 2009.
Information was obtained from 23/71 municipalities approached (representing 200,000 out of 1.5million Arabs). There were 64 confirmed cases of Crohn's disease indicating a prevalence rate of 32/100,000. The rate of smoking within this cohort was lower than in the general population (1.5% vs. 40%; P<0.001). There were 44 confirmed cases of ulcerative colitis with a prevalence rate of 22/100,000. The percentage of active smokers in this cohort was 18%. Clinical remission or mild activity was observed in 75% of patients in both cohorts at the time of the survey. Fourteen patients (21%) had undergone surgery for Crohn's disease, whereas none had undergone surgery for ulcerative colitis. Twenty-eight (42%) patients with Crohn's disease and 20 (45%) with ulcerative colitis were on maintenance therapy with 5-aminosalicylic acid. Only 18% with Crohn's disease and 6.8% with ulcerative colitis had received anti-tumor necrosis factor. The most prevalent extra-intestinal manifestations were perianal disease (18%) in Crohn's disease, and arthralgia or arthritis (6.8%) in ulcerative colitis.
We found a low prevalence rate of inflammatory bowel disease in the Israeli Arab population.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Arabs</subject><subject>Arthralgia - complications</subject><subject>Arthritis - complications</subject><subject>Child</subject><subject>Colitis, Ulcerative - complications</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Colitis, Ulcerative - ethnology</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - ethnology</subject><subject>Crohn Disease - surgery</subject><subject>Crohn's disease</subject><subject>Epidemiology</subject><subject>Family aggregation</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammatory bowel disease</subject><subject>Israel - epidemiology</subject><subject>Maintenance Chemotherapy</subject><subject>Male</subject><subject>Mesalamine - therapeutic use</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Smoking - ethnology</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>Ulcerative colitis</subject><subject>Young Adult</subject><issn>1873-9946</issn><issn>1876-4479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMorq7-A5EcvbTmq2lyEUT8RPCynkM2nbJZ2qYmreK_t2vVo6cZmOedYR6EzijJKaHycpu7GDZdyhmhLCdlTpjcQ0dUlTITotT73z3PtBZygY5T2hJS6KJUh2jBmGZUSHmEnlYbwH2Ed9tA5wCHGvuubmzb2iHET7wOH9DgyiewCaYRth1-TNFC4_F1tGvch35s7OBDd4IOatskOP2pS_R6d7u6ecieX-4fb66fM8d1MWTaQqmlqBmjsgCiqJKqqLQCAqBZQXVNHVGiZIRzJSpdQFW7qpDaaQ6sBL5EF_PePoa3EdJgWp8cNI3tIIzJUM4o54JKNaFiRidVKUWoTR99a-OnocTsLJqtmS2anUVDSjNZnGLnPxfGdQvVX-hX2wRczQBMf757iCY5v_NX-QhuMFXw_1_4AvmihFc</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Zvidi, Ibrahim</creator><creator>Fraser, Gerald M.</creator><creator>Niv, Yaron</creator><creator>Birkenfeld, Shlomo</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130601</creationdate><title>The prevalence of inflammatory bowel disease in an Israeli Arab population</title><author>Zvidi, Ibrahim ; Fraser, Gerald M. ; Niv, Yaron ; Birkenfeld, Shlomo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-9ae7964f22165e0818685d98e0ee92519f1c0847203384d95edfcd569c93e27e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Arabs</topic><topic>Arthralgia - complications</topic><topic>Arthritis - complications</topic><topic>Child</topic><topic>Colitis, Ulcerative - complications</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Colitis, Ulcerative - ethnology</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - ethnology</topic><topic>Crohn Disease - surgery</topic><topic>Crohn's disease</topic><topic>Epidemiology</topic><topic>Family aggregation</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammatory bowel disease</topic><topic>Israel - epidemiology</topic><topic>Maintenance Chemotherapy</topic><topic>Male</topic><topic>Mesalamine - therapeutic use</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Smoking - ethnology</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>Ulcerative colitis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zvidi, Ibrahim</creatorcontrib><creatorcontrib>Fraser, Gerald M.</creatorcontrib><creatorcontrib>Niv, Yaron</creatorcontrib><creatorcontrib>Birkenfeld, Shlomo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Crohn's and colitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zvidi, Ibrahim</au><au>Fraser, Gerald M.</au><au>Niv, Yaron</au><au>Birkenfeld, Shlomo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prevalence of inflammatory bowel disease in an Israeli Arab population</atitle><jtitle>Journal of Crohn's and colitis</jtitle><addtitle>J Crohns Colitis</addtitle><date>2013-06-01</date><risdate>2013</risdate><volume>7</volume><issue>5</issue><spage>e159</spage><epage>e163</epage><pages>e159-e163</pages><issn>1873-9946</issn><eissn>1876-4479</eissn><abstract>To determine the prevalence of inflammatory bowel disease among the 1.5million Arab residents in Israel who represent 20% of the total population.
Family physicians in all Arab towns and villages were contacted to obtain information on patients with inflammatory bowel disease. Relevant clinical data were retrieved and updated to December 31, 2009.
Information was obtained from 23/71 municipalities approached (representing 200,000 out of 1.5million Arabs). There were 64 confirmed cases of Crohn's disease indicating a prevalence rate of 32/100,000. The rate of smoking within this cohort was lower than in the general population (1.5% vs. 40%; P<0.001). There were 44 confirmed cases of ulcerative colitis with a prevalence rate of 22/100,000. The percentage of active smokers in this cohort was 18%. Clinical remission or mild activity was observed in 75% of patients in both cohorts at the time of the survey. Fourteen patients (21%) had undergone surgery for Crohn's disease, whereas none had undergone surgery for ulcerative colitis. Twenty-eight (42%) patients with Crohn's disease and 20 (45%) with ulcerative colitis were on maintenance therapy with 5-aminosalicylic acid. Only 18% with Crohn's disease and 6.8% with ulcerative colitis had received anti-tumor necrosis factor. The most prevalent extra-intestinal manifestations were perianal disease (18%) in Crohn's disease, and arthralgia or arthritis (6.8%) in ulcerative colitis.
We found a low prevalence rate of inflammatory bowel disease in the Israeli Arab population.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>22921466</pmid><doi>10.1016/j.crohns.2012.07.026</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1873-9946 |
| ispartof | Journal of Crohn's and colitis, 2013-06, Vol.7 (5), p.e159-e163 |
| issn | 1873-9946 1876-4479 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1321334168 |
| source | Oxford Journals Online |
| subjects | Adolescent Adult Aged Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Arabs Arthralgia - complications Arthritis - complications Child Colitis, Ulcerative - complications Colitis, Ulcerative - drug therapy Colitis, Ulcerative - ethnology Crohn Disease - drug therapy Crohn Disease - ethnology Crohn Disease - surgery Crohn's disease Epidemiology Family aggregation Female Humans Inflammatory bowel disease Israel - epidemiology Maintenance Chemotherapy Male Mesalamine - therapeutic use Middle Aged Prevalence Smoking - ethnology Tumor Necrosis Factor-alpha - antagonists & inhibitors Ulcerative colitis Young Adult |
| title | The prevalence of inflammatory bowel disease in an Israeli Arab population |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A26%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prevalence%20of%20inflammatory%20bowel%20disease%20in%20an%20Israeli%20Arab%20population&rft.jtitle=Journal%20of%20Crohn's%20and%20colitis&rft.au=Zvidi,%20Ibrahim&rft.date=2013-06-01&rft.volume=7&rft.issue=5&rft.spage=e159&rft.epage=e163&rft.pages=e159-e163&rft.issn=1873-9946&rft.eissn=1876-4479&rft_id=info:doi/10.1016/j.crohns.2012.07.026&rft_dat=%3Cproquest_cross%3E1321334168%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c395t-9ae7964f22165e0818685d98e0ee92519f1c0847203384d95edfcd569c93e27e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1321334168&rft_id=info:pmid/22921466&rfr_iscdi=true |